MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 1, 2015, Pages 166-174

  Yang, Min Hui ^a,b   Hu, Zhi Yan ^a,b   Xu, Chuan ^a,b   Xie, Lin Ying ^a,b   Wang, Xiao Yan ^a,b   Chen, Shi You ^c   Li, Zu Guo ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

AKAP 9; Colorectal cancer; CRC; H E; LncRNA; Long non coding RNA; MALAT1; Metastasis; Metastasis associated lung adenocarcinoma transcript 1; NEAT2; PRKA kinase anchor protein 9; RNAa

Indexed keywords

KINASE ANCHOR PROTEIN 9; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROTEIN; RNA; UNCLASSIFIED DRUG; AKAP9 PROTEIN, HUMAN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYTOSKELETON PROTEIN; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PROMOTER REGION; QUANTITATIVE ANALYSIS; UPREGULATION; COLORECTAL TUMOR; DNA MICROARRAY; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

A KINASE ANCHOR PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, LONG NONCODING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84913553855     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.11.013     Document Type: Article

References (33)

1. Mercer T.R., Mattick J.S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 2013, 20(3):300-307.
2. Nagano T., Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011, 145(2):178-181.
3. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641.
4. Gomes A.Q., Nolasco S., Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int. J. Mol. Sci. 2013, 14(8):16010-16039.
5. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23(13):1494-1504.
6. Schonrock N., Gotz J. Decoding the non-coding RNAs in Alzheimer's disease. Cell. Mol. Life Sci. 2012, 69(21):3543-3559.
7. Bai Y., et al. Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke. Stroke 2014, 45(2):383-388.
8. Xiao X.G., Touma M., Wang Y. Decoding the noncoding transcripts in human heart failure. Circulation 2014, 129(9):958-960.
9. Huang T., et al. Noncoding RNAs in cancer and cancer stem cells. Chin. J. Cancer 2013, 32(11):582-593.
10. Schmitt A.M., Chang H.Y. Gene regulation: Long RNAs wire up cancer growth. Nature 2013, 500(7464):536-537.
11. Lu K.H., et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013, 13:461.
12. Qiao H.P., et al. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac. J. Cancer Prev. 2013, 14(2):1077-1082.
13. Tripathi V., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39(6):925-938.
14. Wilusz J.E., Freier S.M., Spector D.L. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008, 135(5):919-932.
15. Xie L., et al. Expression of long noncoding RNA MALAT1 gene in human nasopharyngeal carcinoma cell lines and its biological significance. Nan Fang Yi Ke Da Xue Xue Bao 2013, 33(5):692-697.
16. Okugawa Y., et al. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014, 35(12):2731-2739.
17. Wu X.S., et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol. Ther. 2014, 15(6):806-814.
18. Gutschner T., et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73(3):1180-1189.
19. Schmidt L.H., et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J. Thorac. Oncol. 2011, 6(12):1984-1992.
20. Rasool S., et al. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour Biol. 2013, 34(5):2469-2476.
21. Xu C., et al. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int. J. Oncol. 2011, 39(1):169-175.
22. Lai M.C., et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29(3):1810-1816.
23. Pushparaj P.N., et al. RNAi and RNAa-the yin and yang of RNAome. Bioinformation 2008, 2(6):235-237.
24. Huang V., et al. RNAa is conserved in mammalian cells. PLoS One 2010, 5(1):e8848.
25. Turner M.J., Jiao A.L., Slack F.J. Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle 2014, 13(5):772-781.
26. Wang J., et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res. 2010, 70(24):10182-10191.
27. Chen R., et al. Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J Sex. Med. 2011, 8(10):2773-2780.
28. Onken M.D., et al. A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease. Clin. Cancer Res. 2014, 20(11):2873-2884.
29. Kabbarah O., et al. Integrative genome comparison of primary and metastatic melanomas. PLoS One 2010, 5(5):e10770.
30. Caria P., Vanni R. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Cancer Genet. Cytogenet. 2010, 203(1):21-29.
31. Lee J.H., et al. BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas. Pathology 2006, 38(3):201-204.
32. Frank B., et al. Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J. Natl. Cancer Inst. 2008, 100(6):437-442.
33. Truong T., et al. International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis 2010, 31(4):625-633.